Literature DB >> 34103940

Vitamin D Deficiency in Children and Adolescents: Role of Puberty and Obesity on Vitamin D Status.

Hedyeh Saneifard1, Marjan Shakiba1, Ali Sheikhy2, Leila Baniadam3, Fatemeh Abdollah Gorji4, Aida Fallahzadeh2.   

Abstract

BACKGROUND: Vitamin D deficiency is common among children and adolescents and can be affected by several factors such as puberty and obesity.
OBJECTIVE: The aim of this study was to evaluate vitamin D status in children and adolescents and to analyse the influence of puberty and obesity on its level.
METHOD: A cross-sectional study was carried-out, in which clinical and biochemical data were gathered from 384 healthy children and adolescents between May 2019 to May 2020.
RESULTS: 220 females and 164 males were enrolled (aged 7-16 years; mean ± SD: 11 ± 2.5). Vitamin D deficiency was found in 49% of the total cases and was significantly more prevalent in females than males (33.1% in female; 15.9% in male, P < .001). Mean vitamin D level was lower in obese children compared with non-obese (P < .001). Non-obese group had significantly higher levels of vitamin D in Tanner stage IV of puberty than obese individuals (20.1 ± 17.0 vs 5.4 ± 2.0) (P = .03). Vitamin D levels were significantly lower in females than males only in Tanner stage II (12.3 ± 9.0 vs 19.6 ± 16.6) (P = .005). The lowest level of Vitamin D was in Tanner stage Ⅳ-Ⅴ in boys and in Tanner stage Ⅱ-Ⅲ in girls (P < .001).
CONCLUSION: Puberty is an additional risk factor for vitamin D deficiency especially in girls and obese children. This increased risk, together with the fact that most important time for building a proper skeleton is during childhood and adolescent, makes it essential to monitor vitamin D in these age groups.
© The Author(s) 2021.

Entities:  

Keywords:  25(OH)2D3; obesity; puberty; season

Year:  2021        PMID: 34103940      PMCID: PMC8161864          DOI: 10.1177/11786388211018726

Source DB:  PubMed          Journal:  Nutr Metab Insights        ISSN: 1178-6388


Introduction

Vitamin D, a fat-soluble vitamin and a pro-hormone, is essential for calcium and phosphorus hemostasis and bone metabolism. The most important sources of vitamin D are sunlight, supplements and diet.[1] The liver and kidneys are 2 essential organs that activate vitamin D as 1,25dihydroxy vitamin D.[2] In addition to bone health and growth, vitamin D plays a crucial role in protecting the body from many conditions such as cancers, cardiovascular events, autoimmune and infectious diseases.[3-5] Hence, in recent years there is an increasing trend in investigating the prevalence and long-term effects of vitamin D deficiency.[6] Vitamin D deficiency is common among children and adolescents and negatively affects bone density, muscle function, glucose metabolism and insulin sensitivity.[7] About 1 billion people in the world have low vitamin D levels; however, the prevalence of its deficiency is still uncertain worldwide.[1] Theoretically, vitamin D deficiency is not expected among people living in regions with intense sunlight. However, some studies indicate a high prevalence of vitamin D deficiency in people who lives in these regions, such as Iran, probably due to clothing, culture and diet.[8-13] Vitamin D level is measured by serum 25-hydroxyvitamin D [25(OH)2D3] and is related to various factors, including race, season, sunlight exposure, diet and adiposity.[14] Furthermore, the prevalence of its deficiency is higher in adolescents compared with prepubertal children; suggesting the effect of puberty on vitamin D levels.[15] The physiologic increase of adipose tissue during puberty decreases the bioavailability of 25(OH)2D3.[16] Besides, puberty is a critical phase in bone development,[17] and there is an increase demand for vitamin D during puberty due to an increase in bone accretion.[18] This study aimed to evaluate the correlation of 25(OH)2D3 status with pubertal stages, winter and summer, BMI, weight and height in children and adolescents.

Subjects and Methods

Subject selection

This is a cross-sectional study conducted in Iran, Tehran, from May 2019 to May 2020. Data were obtained from 384 children and adolescents that referred to paediatric endocrinology clinic. Exclusion criteria were as follows: (1) History of the specific underlying disease (kidney, liver, or seizure, . . .). (2) Specific drug consumption (vitamin D supplements, multivitamins, anticonvulsive drugs). All demographic information and physical examinations, including height, weight and stage of puberty, were taken by a paediatric resident. The stage of puberty was determined according to Tanner scaling.[19] The height and weight of subjects were measured by stadiometer and secca scale. Body mass index (BMI) [weight (Kg)/height (m)[2]] was calculated. Standard deviation score (SDS) (subject’s value – mean value for age and sex of CDC 2000 data/SD) was detected for height, weight and BMI. Obesity is defined as BMI more than 95th percentile according to CDC growth chart-2000. To determine the prevalence of different vitamin D levels, we used the definition of vitamin D deficiency, insufficiency and sufficiency according to the serum level of 25(OH)2D3. Participants were categorized according to the serum level of 25(OH)2D3 into 3 groups according to the classification given by the US Endocrine Society[20]: deficient <20 ng/mL, insufficient 20-30 ng/mL and sufficient >30 ng/mL. After discussing with parents and getting written consent, blood samples were taken in the morning following an overnight fast to measure serum 25(OH)2D3. All subjects gave written informed consent to the use of their health records for analysis. This study was approved by The Research Deputy and Ethics Committee of Shahid Beheshti University of Medical Sciences and Health Services (IR.SBMU.MSP.REC.1391.5), and was conducted in accordance with the Declaration of Helsinki.

Biochemical analysis

Two cc clotted blood sample were taken from the patient and immediately centrifuged for evaluation of serum level of 25(OH)2D3. ELISA method used to evaluate 25(OH)2D3 level. Devices which used was from Biotech, America, furthermore; Euro immune kit, Germany was the main kit in this study.

Anthropometric indices measurement

Weight was assessed with a digital scale (Beurer, GS49, Germany), and only light clothing was allowed. Height was measured using an inflexible measurement tape with a precision of 0.1 cm, with subjects asked to stand erect without shoes and socks. Weight was measured using a portable digital scale with a precision of 0.1 kg. Subjects were asked to wear light clothing. Body mass index (BMI) was calculated on admission by measuring height and weight (kg/height [m2]).

Statistical analysis

Data were analysed by using SPSS 25 (SPSS Inc, Chicago). Means and standard deviations were used to summarize continuous variables that were normally distributed. The normality of 25-hydroxy vitamin D levels was checked by Kolmogorov–Smirnov test, which used non-parametric tests because P-value was less than .05. Statistically significant differences were tested for quantitative items by Mann–Whitney and Kruskal–Wallis tests and for qualitative items by Fisher’s exact and χ2 tests. Multinominal regression analysis was made to evaluate the relative risk for each variable.

Results

The clinical characteristics of the study group are shown in Table 1. Three hundred and eighty-four healthy children and adolescents (220 females; 164 males) were enrolled in this study. Their age was 7 to 16 years old (mean ± SD: 11 ± 2.5). Vitamin D deficiency was found in 49% of the total cases and was significantly more prevalent in females than males (33.1% in females; 15.9% in males, P < .001). Table 2 illustrates the characteristic of subjects according to vitamin D status. The total level of vitamin D was significantly lower in females than in males (16.8 ± 15.3 vs 20.5 ± 14.9) (P < .001). The mean level of vitamin D in vitamin D deficient subjects was also significantly lower in females than males (7.9 ± 2.8 vs 8.8 ± 3.5) (P = .026), but the difference was not significant in sufficient and insufficient groups. There was no significant difference between mean serum levels of vitamin D in different age groups. There was no statistical correlation between total vitamin D level with height (P-value: 0.144) and weight percentiles (P-value: 0.106). In the vitamin D deficient group, vitamin D was significantly higher in weight percentile <3% (P = .045). Total 25(OH)2D3 level was significantly higher in Tanner stage I (mean ± SD: 22.7 ± 15.7) (P < .001) and lower in Tanner stage V (mean ± SD: 14.6 ± 13.8) (P < .001), and it had inverse relationship with BMI percentile (P = .023). Table 3 illustrates the mean vitamin D status according to the obese and non-obese groups’ pubertal stage. Mean vitamin D level was lower in obese children compared with non-obese (P < .001). The non-obese group had significantly higher vitamin D levels in Tanner stage Ⅳ than obese individuals (20.1 ± 17.0 vs 5.4 ± 2.0) (P = .03). We found differences in vitamin D levels in Tanner stage Ⅱ-Ⅴ with regards to Tanner stage Ⅰ in both obese and non-obese groups (P < .001). Vitamin D levels were significantly lower in females than males only in Tanner stage Ⅱ (12.3 ± 9.0 vs 19.6 ± 16.6) (P = .005). The lowest level of Vitamin D was in Tanner stage Ⅳ-Ⅴ in boys and Tanner Ⅱ-Ⅲ in girls (P < .001) (Table 4). Relative risk for Vitamin D deficiency reported in Table 5. Female gender, age, puberty and winter season estimated as risk factor for vitamin D deficiency, which could be also found in Figure 1.
Table 1.

Characteristic of the study subjects.

CharacteristicFemaleMaleP-valueTotal
n: 220n: 164n: 384
Vitamin D statusDeficient127 (33.1%)61 (15.9%)<.001188 (49%)
Insufficient63 (16.4%)69 (18%)132 (34.4%)
Sufficient30 (7.8%)34 (8.9%)64 (16.7%)
Age7.0-10.99150 (68.2%)61 (37.2%)<.001211 (54.9%)
11.0-13.9943 (19.5%)64 (39%)107 (27.9%)
14.0-16.9927 (12.3%)39 (23.8%)66 (17.2%)
Height percentile<3%29 (13.2%)25 (15.2%).43254 (14.1%)
3%-97%187 (85%)133 (81.1%)320 (83.3%)
⩾97%4 (1.8%)6 (3.7%)10 (2.6%)
Weight percentile<3%24 (10.9%)17 (10.4%).24441 (10.7%)
3%-97%167 (75.9%)115 (70.1%)282 (73.4%)
⩾97%29 (13.2%)32 (19.5%)61 (15.9%)
BMI percentile<5%21 (9.5%)12 (7.3%).43833 (8.6%)
5%-95%138 (62.7%)113 (68.9%)251 (65.4%)
⩾95%61 (27.7%)39 (23.8%)100 (26%)
Puberty stage177 (35%)70 (42.7%).51147 (38.3%)
248 (21.8%)44 (26.8%)92 (24%)
334 (15.5%)25 (15.2%)59 (15.4%)
417 (7.7%)9 (5.5%)26 (6.8%)
544 (20%)16 (9.8%)60 (15.6%)
SeasonSpring and summer106 (48.2%)79 (48.2%)1.0185 (48.2%)
Autumn and winter114 (51.8%)85 (51.8%)199 (51.8%)
Table 2.

Characteristic of subjects according to vitamin D status.

CharacteristicTotalVitamin D deficientVitamin D insufficientVitamin D sufficientP-value
No. of participants38418813264
Serum 25(OH)2D318.4 ± 15.28.2 ± 3.119.8 ± 4.345.5 ± 16.5<.001
Sex
 Female16.8 ± 15.37.9 ± 2.820.2 ± 4.247.6 ± 18.2<.001
 Male20.5 ± 14.98.8 ± 3.519.4 ± 4.443.7 ± 14.9<.001
P-value<.001.026.272.303
Age
 7-1020.1 ± 16.88.0 ± 2.920.0 ± 4.447.5 ± 16.9<.001
 11-1416.1 ± 11.58.1 ± 3.319.6 ± 4.340.3 ± 9.3<.001
 14-1616.6 ± 14.48.7 ± 3.219.3 ± 4.043.5 ± 22.0<.001
P-value.180.490.789.298
Height percentile
 <3%18.8 ± 17.87.5 ± 3.521.5 ± 4.964.6 ± 22.1<.001
 3%-97%18.6 ± 15.18.2 ± 3.019.4 ± 4.143.9 ± 15.2<.001
 ⩾97%10.2 ± 3.99.3 ± 2.818.5.200
P-value.144.303.193.023
Weight percentile
 <3%20.8 ± 16.19.7 ± 2.820.9 ± 4.752.2 ± 9.3<.001
 3%-97%18.4 ± 14.67.9 ± 3.319.6 ± 4.344.3 ± 15.2<.001
 ⩾97%16.8 ± 17.28.3 ± 2.419.5 ± 3.646.5 ± 25.1<.001
P-value.106.045.585.095
BMI percentile
 <5%22.5 ± 15.39.1 ± 3.022.2 ± 4.750.1 ± 8.1<.001
 5%-95%18.2 ± 14.18.2 ± 3.519.5 ± 4.344.5 ± 14.4<.001
 ⩾95%17.6 ± 17.57.9 ± 2.019.2 ± 3.846.0 ± 22.2<.001
P-value.023.252.090.219
Puberty stage
 122.7 ± 15.78.9 ± 2.919.8 ± 4.345.9 ± 15.2<.001
 215.8 ± 13.68.5 ± 3.320.1 ± 4.341.2 ± 18.5<.001
 316.6 ± 15.27.4 ± 3.118.5 ± 5.046.8 ± 14.3<.001
 416.0 ± 15.27.1 ± 3.723.3 ± 3.351.5 ± 6.7<.001
 514.6 ± 13.88.2 ± 2.619.2 ± 3.747.8 ± 29.2<.001
P-value<.001.133.092.294
Season
 Spring and summer19.7 ± 17.78.1 ± 3.219.1 ± 4.146.6 ± 19.2<.001
 Autumn and winter17.1 ± 12.48.3 ± 3.020.3 ± 4.443.6 ± 10.8<.001
P-value.385.601.084.912
Table 3.

Mean vitamin D status according to the pubertal stage in obese and non-obese groups.

Pubertal stageObese groupNon-obese groupP-value
No.25(OH)2D3No.25(OH)2D3
Mean ± SDMean ± SD
13922.7 ± 19.39622.9 ± 14.4.373
23516.7 ± 18.15515.3 ± 10.3.358
3718.3 ± 18.45116.4 ± 15.1.583
465.4 ± 2.01720.1 ± 17.0.030
5139.9 ± 5.64715.9 ± 15.2.054
Total10017.6 ± 17.526618.6 ± 14.4<.001
P-value<.001<.001
Table 4.

Mean vitamin D status according to the pubertal stages in males and females.

Pubertal stageMaleFemaleP-value
No.25(OH)2D3No.25(OH)2D3
Mean ± SDMean ± SD
17023.2 ± 14.57722.2 ± 16.9.410
24419.6 ± 16.64812.3 ± 9.0.005
32520.6 ± 15.93413.6 ± 14.2.068
4912.3 ± 9.81717.9 ± 17.4.458
51615.4 ± 9.04414.3 ± 15.3.176
Total16420.5 ± 14.922016.8 ± 15.3<.001
P-value.030<.001
Table 5.

Relative risks for vitamin D deficiency and insufficiency.

VariableDeficiencyInsufficiency
Relative risk [95% CI]P valueRelative risk [95% CI]P value
Female2.360 [1.325, 4.206].0041.035 [0.569, 1.882].911
Age1.186 [1.055, 1.334].0041.066 [0.943, 1.206].306
Obesity1.203 [0.969, 1.493].0950.881 [0.700, 1.170].277
Puberty stage1.518 [1.210, 1.903]<.0011.087 [0.854, 1.386].497
Winter and autumn season1.854 [1.037, 3.316].0372.262 [1.226, 4.174].009
Figure 1.

Relative risk for vitamin D deficiency.

Characteristic of the study subjects. Characteristic of subjects according to vitamin D status. Mean vitamin D status according to the pubertal stage in obese and non-obese groups. Mean vitamin D status according to the pubertal stages in males and females. Relative risks for vitamin D deficiency and insufficiency. Relative risk for vitamin D deficiency.

Discussion

In this study, we evaluated the vitamin D status in 384 healthy children and adolescents. The prevalence of vitamin D deficiency was 49% and was more prevalent in girls than boys. Our study demonstrated an inverse relationship between total 25(OH)2D3 level and BMI percentiles. We also evaluated the association between vitamin D level and pubertal stages. Serum level of 25(OH)2D3 decreased after the onset of puberty. Vitamin D was lowest in Tanner stage Ⅳ-Ⅴ in boys and Tanner stage Ⅱ-Ⅲ in girls. Girls had lower levels of vitamin D than boys in Tanner stage Ⅱ. Obese children had lower vitamin D levels in Tanner stage Ⅳ and Ⅴ compared with the non-obese group. Vitamin D deficiency has been reported with high frequency among Iranian children and adolescents and may be related to insufficient sun exposure, type of clothing, lack of receiving sufficient amount of vitamin D and low physical activity. Like our results, Saki et al[21] conducted a study in southern Iran and showed that vitamin D deficiency was highly prevalent (81.3%) among children and adolescents. In agreement with our study, Moussavi et al[8] and Razzaghy-Azar et al[22] showed that vitamin D deficiency was more frequent in girls than boys. Puberty is a period of transition from childhood to adulthood, during which thelarche, adrenarche, pubarche, peak height velocity (PHV), and ultimately menarche occurs in girls and gonadarche, pubarche and PHV occur in boys. The mean age of PHV is 11.9 years in girls and 14.2 years in boys.[23] Tanner-stage determined according to Marshall-Tanner criteria, which is based on secondary sexual characteristics, breast stages in girls and genital development by inspection in boys.[19] The categories are divided into 5 main groups including, Tanner Stage I (prepubertal), Tanner Stage II (early puberty), Tanner Stage III (mid-puberty), Tanner Stage IV (mid-puberty) and Tanner Stage V (late puberty/adult). Peak height velocity occurs in Tanner stage Ⅱ and Ⅳ in most girls and boys respectively.[24,25] Hence, puberty is a crucial time in bone mineral mass development, and vitamin D demand increases in this period.[26] Our study found that vitamin D level was lower in girls in Tanner stage II and III, and boys in Tanner stage IV and V. This may be due to pubertal growth spurt in these stages. Cediel et al[18] conducted a cohort study in Santiago, Chile. In agreement with our results, they found that there is a significant decline in serum 25(OH)2D3 level between prepuberty (Tanner stage 1) and puberty onset (Tanner stage 2) in both boys and girls. Obesity is associated with early puberty due to elevated leptin level, which have a permissive effect on puberty and pubertal growth.[27] There is an association between increasing BMI and lower serum 25-hydroxyvitamin D3 concentrations[28]; this may be due to reduced cutaneous synthesis and intestinal absorption, altered metabolism and sequestration of 25(OH)2D3 in adipose tissue in obese individuals.[29] Vitamin D receptors (VDR) are present on human adipocytes, and 25(OH)2D3 appears to influence lipogenesis, lipolysis, adipogenesis and reducing adipose tissue inflammation.[30-33] Besides, low vitamin D status can lead to obesity due to secondary hyperparathyroidism and an increase in intracellular calcium.[34,35] Moreover, there are evidences that vitamin D supplementation may prevent obesity.[32,35] Similar to our findings, Reis et al,[36] in a study of 3377 adolescents, found significantly low levels of vitamin D in subjects with BMI percentile >95. Another study done by Gutiérrez Medina et al[37] showed that vitamin D deficiency was more prevalent in obese children. Razzaghy-Azar et al[22] conducted a cross-sectional study in Iran, Tehran. They showed that vitamin D deficiency was more prevalent in females than males, and the serum level of 25(OH)2D3 decreased after the onset of puberty. Moreover, they found a negative correlation between serum level of 25(OH)2D3 and BMI-SDS, similar to our observations. Another cross-sectional, conducted by Gutiérrez Medina et al,[37] reported a higher vitamin D deficiency in the pubertal group than the prepubertal group. In constant with our results, they found lower levels of vitamin D in pubertal obese subjects compared with their prepubertal counterparts. In this study, we indicated that there is no significant difference in vitamin D levels according to seasonal changes. In agreement with our results, several studies showed that the prevalence of vitamin D deficiency did not differ by seasonal changes and remained stable even in sunny climates.[38-40] Accordingly, it could be emphasized that seasonal variations do not reduce vitamin D levels significantly, and other factors are also contributed between changes in vitamin D levels over different seasons. Our study has several limitations, such as its cross-sectional nature, the absence of a nutritional survey, and the absence of data about exercise and sun exposure.

Conclusion

Vitamin D deficiency is common among Iranian children and adolescents despite the sunny climate. This study demonstrated that puberty is an additional risk factor for vitamin D deficiency, especially in girls and obese children. This increased risk, together with the fact that the most crucial time for building a proper skeleton is during childhood and adolescence, makes it essential to monitor vitamin D in these age groups. However, further longitudinal studies are required to evaluate the influence of puberty and obesity on vitamin D levels.
  37 in total

1.  Evolutionary perspective on human growth.

Authors:  B Bogin
Journal:  Annu Rev Anthropol       Date:  1999

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Vitamin D status and cardiometabolic risk factors in the United States adolescent population.

Authors:  Jared P Reis; Denise von Mühlen; Edgar R Miller; Erin D Michos; Lawrence J Appel
Journal:  Pediatrics       Date:  2009-08-03       Impact factor: 7.124

4.  Decreased bioavailability of vitamin D in obesity.

Authors:  J Wortsman; L Y Matsuoka; T C Chen; Z Lu; M F Holick
Journal:  Am J Clin Nutr       Date:  2000-09       Impact factor: 7.045

5.  Vitamin D and hyperparathyroidism in obesity.

Authors:  Elizabeth Grethen; Ronald McClintock; Christine E Gupta; RoseMarie Jones; Brenda M Cacucci; David Diaz; Angie D Fulford; Susan M Perkins; Robert V Considine; Munro Peacock
Journal:  J Clin Endocrinol Metab       Date:  2011-02-16       Impact factor: 5.958

6.  [Ultraviolet radiation impact on seasonal variations of serum 25-hydroxy-vitamin D in healthy young adults in Buenos Aires].

Authors:  Pablo R Costanzo; Pablo R Constanzo; Natalia O Elías; Jessica Kleiman Rubinsztein; Natalia X García Basavilbaso; Rubén Piacentini; Helena H Salerni
Journal:  Medicina (B Aires)       Date:  2011       Impact factor: 0.653

7.  The relation of vitamin D deficiency with puberty and insulin resistance in obese children and adolescents.

Authors:  Muammer Buyukinan; Samim Ozen; Serap Kokkun; Eylem Ulas Saz
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

8.  Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Anders Borglykke; Torben Jørgensen; Betina Heinsbæk Thuesen; Charlotta Pisinger; Lars Ebbe Schmidt; Allan Linneberg
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

Review 9.  Vitamin D and obesity.

Authors:  Simon Vanlint
Journal:  Nutrients       Date:  2013-03-20       Impact factor: 5.717

10.  Vitamin D deficiency and causative factors in the population of Tehran.

Authors:  Sima Hashemipour; Bagher Larijani; Hossein Adibi; Ebrahim Javadi; Mojtaba Sedaghat; Mohammad Pajouhi; Akbar Soltani; Ali Reza Shafaei; Zohreh Hamidi; Ali Reza Khalili Fard; Arash Hossein-Nezhad; Fargol Booya
Journal:  BMC Public Health       Date:  2004-08-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.